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Abstract
Objective Little is known about the prevalence and degree of deformation of surgically implanted aortic biological valve
prostheses (bio-sAVRs). We assessed bio-sAVR deformation using multidetector-row computed tomography (MDCT).
Methods Three imaging databases were searched for patients with MDCT performed after bio-sAVR implantation. Minimal and
maximal valve ring diameters were obtained in systole and/or diastole, depending on the acquired cardiac phase(s). The eccen-
tricity index (EI) was calculated as a measure of deformation as (1 − (minimal diameter/maximal diameter)) × 100%. EI of < 5%
was considered none or trivial deformation, 5–10% mild deformation, and > 10% non-circular. Indications for MDCT and
implanted valve type were retrieved.
Results One hundred fifty-two scans of bio-sAVRswere included. One hundred seventeenmeasurements were performed in systole
and 35 in diastole. None or trivial deformation (EI < 5%) was seen in 67/152 (44%) of patients. Mild deformation (EI 5–10%) was
seen in 59/152 (39%) and non-circularity was found in 26/152 (17%) of cases. Overall, median EI was 5.5% (IQR 3.4–7.8). In 77
patients, both systolic and diastolic measurements were performed from the same scan. For these scans, the median EI was 6.5%
(IQR 3.4–10.2) in systole and 5.1% (IQR3.1–7.6) in diastole, with a significant difference between both groups (p = 0.006).
Conclusions Surgically implanted aortic biological valve prostheses showmild deformation in 39% of cases and were considered
non-circular in 17% of studied valves.
Key Points
• Deformation of surgically implanted aortic valve bioprostheses (bio-sAVRs) can be adequately assessed using MDCT.
• Bio-sAVRs show at least mild deformation (eccentricity index > 5%) in 56% of studied cases and were considered non-circular
(eccentricity index > 10%) in 17% of studied valves.
• The higher deformity rate found in bio-sAVRs with (suspected) valve pathology could suggest that geometric deformity may play
a role in leaflet malformation and thrombus formation similar to that of transcatheter heart valves.
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Abbreviations
AVR Aortic valve replacement
Bio-sAVR Biological surgical aortic valve replacement
EI Eccentricity index
IQR Interquartile range
MDCT Multidetector-row computed tomography
sAVR Surgical aortic valve replacement
SVD Structural valve deterioration
TAVI Transcatheter aortic valve implantation
THV Transcatheter heart valve
Introduction
Approximately 280,000 valve prostheses are implanted
worldwide each year: 20% of which are mechanical valves
and 80% bioprosthetic valves. Bioprostheses are increasingly
chosen due to favorable hemodynamic profile, longer durabil-
ity with recent generations of bioprosthetic valves, and low
thrombogenicity [1, 2]. In spite of significant improvement of
bioprosthesis design and surgical procedures, the implantation
does not necessarily result in a definitive cure, and native
valve disease is often replaced by “prosthetic valve disease”
[3]. Structural valve deterioration (SVD) is the major cause of
surgical aortic valve bioprosthesis (bio-sAVR) failure, which
increases with time post implantation. The reoperation rate for
biological valves in the aortic position is 10% at 10 years and
30% at 15 years [4]. In transcatheter heart valves (THV),
deformity of the valves after implantation has been a key
concern in several studies [5–8] and non-circularity of the
prosthesis has been found in up to a third of cases [9–11].
The self-expandable valves in particular show deformation
of the valve in up to 36% of cases at the level of the aortic
annulus [10, 12, 13]. Deformation of surgical biological
valves may result in incomplete leaflet expansion, and subse-
quently accelerate valve degeneration; it may also alter me-
chanical stress distribution and facilitate valve leaflet throm-
bosis and calcification [14–16] but has not been assessed in
large prospective clinical studies. Most bio-sAVRs have a
frame that supports the leaflets but this frame can be easily
deformed by external forces (Video File 1). It is conceivable
that deformation of bio-sAVR after implantation could occur
post implantation. The aim of this study was to assess the
deformity of bio-sAVR after surgical implantation using
multidetector-row computed tomography (MDCT).
Patients and methods
Patients
We performed a retrospective search in three medical data-
bases (UMC Utrecht 2007–2014, EMC Rotterdam 2012–
2019, and Duke UMC Durham 2016–2018), for patients with
a bio-sAVR and available ECG-gatedMDCTexams. Stentless
valves and THVs were excluded. In patients with multiple
ECG-gatedMDCTacquisitions, the acquisition closest to date
of implantation was included for analysis. The implanted
valve type and size, indication for MDCT, and time from
implantation toMDCT imaging were collected. Both prospec-
tively ECG-gated and retrospectively ECG-gated acquisitions
were included.
Image analysis
For each acquisition, we selected the best systolic and diastol-
ic cardiac phase with least bio-sAVR-related artifacts and best
subjective image quality. When both systolic and diastolic
phases were available, systolic measurements were utilized
for overall measurements. We preferred systolic measure-
ments because this is considered the most important phase
for sizing in pre-surgical imaging.
Images were reconstructed in three planes using the
multiplanar tool available on a dedicated commercially
available workstation (Intellispace Portal, Philips
Healthcare, and Syngo.via, Siemens Healthineers).
Images were reconstructed exactly in plane enface with
the prosthesis. Three observers, DS, MEF, and FRS, with
respectively 7-, 5-, and 1-year experience in cardiac im-
aging, measured the maximal and minimal inner valve
diameter for each valve in systole and diastole, when
available. This was done by tracing the perimeter at the
level of the bio-sAVR ring and/or stent where it was
visible as a complete (circular) structure. The software
automatically generated minimal and maximal diameter
measurements perpendicular to each other, as presented
in Fig. 1 and Video File 2.
The eccentricity index (EI) was calculated for both cardiac
phases as EI = (1 − (minimal diameter/maximal diameter)) ×
100%. The eccentricity of the bio-sAVRwas considered none/
trivial (circular) with an EI < 5%, mild with an EI 5–10%, and
non-circular with an EI of > 10% (Fig. 2) [7, 9].
Statistical analysis
IBM SPSS Statistics 24.0 software was used for analysis. QQ-
plots and Shapiro-Wilk test were performed to evaluate data
distribution. Categorical data are presented as number and
percentage, continuous data as mean ± standard deviation, or
median and interquartile range (IQR) as appropriate. Since
data were not normally distributed, the Wilcoxon signed rank
test was used for paired systolic and diastolic EI measurement
comparison. For independent data, the Mann-Whitney U test
was used. A p value of ≤ 0.05 was considered significant.
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Results
Two hundred patients with stented biological valves in the
aortic position and ECG-gated MDCT imaging exams were
identified. Of these, 34 were transcatheter valves and excluded
from further analysis. Twelve Mitroflow aortic valves
(LivaNova PLC) were excluded due to the unique structure
with leaflets mounted outside the stent frame and a radiopaque
sewing ring that is always eccentric as it adapts to the annulus.
Two patients were excluded due to notable artifacts rendering
accurate measurements unobtainable. The final cohort
included 152 scans of bio-sAVR (Table 1). The vast majority
of studied valves concerned the Carpentier-Edwards
Perimount valve (Edwards Lifesciences Inc.): 120/152 valves
(79%).
In 84 of 152 scans (55%), bio-sAVRMDCTwas performed
for routine postoperative follow-up, study purposes, or for
other reasons than primary prosthetic valve assessment. In
41 of 152 scans (27%), MDCTwas performed for evaluation
of suspected bio-sAVR endocarditis, regurgitation, obstruc-
tion, or dysfunction. In the remaining 27 of 152 scans
(18%), MDCT performed as part of pre-surgical planning,
Fig. 1 Demonstration of measurement acquisition: example of in-plane
measurements of the minimal and maximal inner valve diameters of a
biological valve prosthesis in aortic position. In this patient, both systolic
(a, b) and diastolic (c, d) measurements were available. Images were
reviewed in three planes using a multiplanar tool, reconstructing an
image exactly in plane enface with the prosthesis (a, c). Perimeter was
traced at the level of the AVR ring and/or stent where it was visible as a
complete (circular) structure. The software automatically generated
minimal and maximal diameters perpendicular to each other (b, d)
Fig. 2 Range of eccentricity of biologic surgical aortic valves on cardiac
MDCT exams: examples of varying degree of eccentricity of the same
type of aortic biological valve in three different patients. Eccentricity was
defined as follows: none/trivial (circular) < 5%, mild 5–10%, and non-
circular > 10% eccentricity based on the eccentricity index calculated as
(1 − (minimal diameter/maximal diameter)) × 100
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e.g., pre “transcatheter aortic valve implantation” (TAVI) in
failed bio-sAVR. Median time between bioprosthesis implan-
tation andMDCTwas 12months (IQR 2–82). For one patient,
implantation date was unknown. Overall, 52/151 (34%) scans
were performed less than 3 months after implantation, 23/151
(23%) scans between 3 and 12 months after implantation, and
76/151 (50.5%) scansmore than 12months after implantation.
In this last group, 33/151 (22%) were performed between 1
and 5 years after implantation and 43/151 (28.5%) were ac-
quired more than 5 years after.
Of the 152 scans, 117 had systolic measurements and 112
had diastolic measurements, resulting in a total of 229 mea-
surements performed for the 152 scans. In these 152 scans, 77
had systolic and diastolic measurements since both phases
were scanned in these patients. Forty scans had systolic mea-
surements only and 35 scans had diastolic measurements only.
If both systolic and diastolic measurements were available,
systolic measurements were utilized for the analysis.
Therefore, a total of 117 systolic measurements and 35 dia-
stolic measurements were used for the overall analysis. None
or trivial deformation (EI < 5%) was seen in 67/152 (44%) of
patients, 49/117 (42%) in systole, and 18/35 (51%) in diastole.
Mild deformation (EI 5–10%)was seen in 59/152 (39%) scans
overall and 45/117 (38%) and 14/35 (40%) measurements in
systole and diastole, respectively; whereas non-circularity was
found in a total of 26/152 (17%) scans, 23/128 (20%) and 3/35
(9%) in systole and diastole, respectively (Table 2). Only one
of these non-circular valves had an EI > 20%, with an EI of
30.8 in systole and 26.7 in diastole. Overall, median EI was
5.5% (IQR 3.4–7.8) for all 152 scans, 5.8% (IQR 3.4–8.5) in
the 117 systolic scans, and 4.9% (IQR 2.7–6.6) in the 35
diastolic scans, which was significantly different (p = 0.05).
In 77 patients, measurements in both systole and diastole
were performed. For these scans, the median EI was 6.5%
(IQR 3.4–10.2) in systole and 5.1% (IQR3.1–7.6) in diastole,
with a significant difference between both groups (p = 0.006).
Table 3 shows median valve eccentricity, stratified by valve
type. There was a significant difference between the median
EI of scans performed for suspected valve pathology and
scans done for follow-up, study purpose, or other pathologies.
In the group with suspected valve pathology, median EI was
6.9% (IQR3.4–10.6) compared with median EI 5.0%
(IQR3.3–6.9) in the group without suspected dysfunction
(p = 0.023).
Discussion
In the current study, we evaluated the degree of geometrical
deformation of aortic biological valve prostheses after surgical
implantation on MDCT and found a considerable number of
bioprostheses to show valve deformation. At least mild defor-
mation was found in 56% (85/152) of biological valves of
which 17% (26/152) were considered non-circular.
Table 1 Parameters of surgical aortic biological valves assessed
Total, N = 152
Bioprosthesis type
Carpentier-Edwards Perimount (Edwards Lifesciences) 120 (79%)
Mosaic (Medtronic) 7 (4.6%)
CE Perimount Magna Aortic (Edwards Lifesciences) 11 (7.2%)
Biocor/Epic (St. Jude Medical*) 2 (1.3%)
Avalus (Medtronic) 1 (0.7%)
Edwards Intuity Elite (Edwards Lifesciences) 1 (0.7%)
Mosaic Ultra (Medtronic) 1 (0.7%)
Trifecta (St Jude Medical*) 1 (0.7%)
Perceval (Sorin Group**) 1 (0.7%)
Unknown 7 (4.6%)
Prosthesis size
19 mm 2 (1.3%)
21 mm 19 (12.5%)
23 mm 39 (25.7%)
25 mm 51 (33.6%)
27 mm 31 (20.4%)
29 mm 2 (1.3%)
Unknown 8 (5.3%)
Reason for performing MDCT
Postoperative evaluation (no pathology) 33 (21.7%)
Research purpose (no pathology) 32 (21.1%)
Other - NonPHV-related 19 (12.5%)
Presurgery/TAVI (failed AVR) 27 (17.7%)
Suspected endocarditis 22 (14.5%)
Suspected obstruction 7 (4.6%)
Suspected leakage (non-endocarditis) 3 (2.0%)
Suspected dysfunction (general) 9 (5.9%)
Time implant to MDCT (months) 12 [2–82]
Data presented as number (percentage) or median [interquartile range]
*Acquired by Abbott Laboratories
**Merged in LivaNova PLC
Table 2 Degree of deformation of biological surgical aortic valve
Total Systolic phase Diastolic phase
N = 152 N = 117 N = 35
None/trivial eccentricity 67 (44%) 49 (42%) 18 (51%)
Mild eccentricity 59 (39%) 45 (38%) 14 (40%)
Non-circular 26 (17%) 23 (20%) 3 (9%)
Eccentricity was defined as follows: none/trivial < 5%, mild 5–10%, and
non-circular > 10% eccentricity
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Previous studies have shown that mechanical stress can
impact the (pathological) tissue calcification process, which
affects valve durability [3, 14, 15, 17, 18]. It has also been
suggested that structural deformation might contribute to the
valve calcification process [14, 19]. As deformation of the
prosthetic heart valve stent can impact leaflet composition
and stress distribution, bioprostheses with significant defor-
mation may be more prone to leaflet thrombosis and (early)
structural valve deterioration [16]. Our study found a signifi-
cant higher deformity in bio-sAVRs with (suspected) valve
pathology as compared with supposedly normal functioning
valves, supporting this hypothesis.
We found a considerable portion of implanted bio-sAVRs
to show deformation of any extent. Literature on the preva-
lence and degree of deformation of surgical bioprostheses is,
however, scarce. To our knowledge, this is the first study
assessing the geometry of surgically implanted biological aor-
tic valves on CT. Deformation of THVs has been evaluated
extensively, showing non-circularity in 0–34% balloon-
expandable and up to 87% in self-expandable valves [5–7,
9, 11, 20–22]. These results can, however, not be extrapolated
to surgical valves, since surgical valves differ fundamentally
from THVs both in configuration and structure as well as
technique of implantation. Hence, the underlying mechanism
of deformation is likely to differ between bio-sAVRs and
THV. With surgical aortic valve replacement, native annular
calcifications are typically resected before valve implantation,
whereas for transcatheter implantation, a certain amount and
distribution is needed for prosthesis positioning and deploy-
ment. While annular calcifications have been reported to im-
pact TAVI stent deployment and eccentricity [2, 3], this is not
likely impacting deformation of bio-sAVRs [23–25].
Deformation of bio-sAVRs might, however, be induced by
the implantation technique, as well as by the annulus geome-
try that may change after annular calcification resection. It
seems plausible that bio-sAVRs can undergo deformation
due to the forces exerted by surgical sutures on the sewing
ring, especially if the sutures are distributed unequally.
Deformation may also be related to the design of specific
bio-sAVR types. Statistical analysis stratified for the degree of
deformation by bio-sAVR type was not feasible in this study
as valve type was dominated by CE Perimount (79%), so
results may be limited in regard to extrapolation across valve
types.
We previously reported on the variation in change of the
native aortic annulus throughout the cardiac cycle which has
been shown to be predominantly oval in diastole and circular
in systole [26, 27]. In our study, the bio-sAVRs showed a
significantly lower EI (i.e., more circular shape) in diastole
(5.1% [IQR 3.0–7.6]) compared with systole (6.5% [IQR
3.4–10.2]) suggesting that similar to the native annulus con-
formational changes occur with bio-sAVR albeit more circular
in diastole for bio-sAVR vs. systole for native aortic valves.
Our study found a significantly higher deformity rate in
bio-sAVRs with (suspected) valve pathology as compared
with those imaged for routine or study purposes (median EI
6.9% versus 5.0%, respectively), although the difference was
relatively small. One could postulate that geometric deformity
may lead to increase in leaflet malformation and thrombus
formation similar to that of THV, but this is only hypothesis
generating.
There are several limitations to our study. First, no inter-
and intra-observer variability for EI measurements was per-
formed. However, excellent reproducibility for diameter mea-
surements in prosthetic valves using CTwas shown previous-
ly using similar methodology [28]. Also, in THVs, no differ-
ence between MDCT and three-dimensional transesophageal
echocardiography was found for annular eccentricity assess-
ment [29]. Second, the time range from implant toMDCTwas
relatively large, with 34% performed ≤ 3 months and 28.5%
performed ≥ 5 years after implantation. Third, because of the
retrospective design, the impact of surgical implantation tech-
niques could not be evaluated and the cohort was too small to
study the effects of different bio-sAVR types. Future studies
may provide insight on differences between specific sAVR
types, implantation techniques, and the degree of deformation.
To conclude, biological sAVRs in this study showed mild
geometric deformation in 39% of cases and were considered
non-circular in an additional 17% of studied valves onMDCT
at a median of 12 months (IQR 2–82) after implantation. We
found a significantly higher deformity in aortic valves referred
for imaging with suspected valve pathology compared with
Table 3 Degree of eccentricity of
biological surgical aortic valve
degree related to time of
reconstruction in the cardiac cycle
Eccentricity*
Biological valve type N Systolic N Diastolic p value
CE Perimount 92 5.2% [3.1–7.4%] 84 4.7% [2.8–6.3%] 0.21
Medtronic Mosaic 6 10.5% [7.0–14.0] 7 10.6% [4.0–11.3] 0.39
CE Perimount Magna aortic 8 7.7% [6.0–10.7] 10 4.9% [3.1–9.2] 0.11
Other types/unknown 11 6.8% [3.4–10.6%] 11 5.5% [2.9–7.8%] 0.31
N = total number valves evaluated; since some valves are measured in both systole and diastole, total number of
valves in this table exceeds 160; *Presented as median [interquartile range], measured as (1 − (minimal diameter/
maximal diameter)) × 100
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those being imaged for routine surveillance. Our results are
hypothesis-generating and future studies are needed to evalu-
ate the prognostic value of biological aortic valve deformation
on structural valve durability and assess differences among
valve types and surgical implantation techniques.
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